Plasma Urea Research Articles

Effects of Fermented Soybean Hulls on Reproductive Performance, Blood Physiology and Immune Parameters Along with Fecal Microbiota in Sows

This study aims to investigate the effects of fermented soybean hulls (FSHS) on reproductive performance, plasma biochemical profiles, immune parameters, and fecal microbiota in sows. A total of 325 sows were randomized into five groups, each fed a diet with varying FSHS proportions: 0% (control), 2% (FSHS2), 4% (FSHS4), 6% (FSHS6), and 8% (FSHS8). Diets were prepared by replacing conventional soybean hulls with FSHS in equal amounts. The study lasted from day 30 to day 110 of gestation. The results indicated the following: (1) Reproductive Performance: The number of live piglets per litter, newborn litter weight, and individual piglet weight increased linearly with the increase in FSHS addition in the diet (PLinear < 0.05). A trend toward reduced farrowing duration was observed when FSHS was added to the diet (PLinear = 0.076). FSHS improved newborn weight and weight variation compared to the control when FSHS was added to the diet (PAnova < 0.05). Replacing soybean hulls with FSHS also increased fecal scores, enhancing fecal consistency and alleviating constipation (p < 0.01). (2) Plasma Biochemical Indicators: Plasma urea concentration on day 60 decreased linearly with increasing FSHS (PLinear < 0.05). Plasma total protein and aspartate aminotransferase (AST) activities showed quadratic effects (PQuadratic < 0.05) on day 60 and 90 of gestation, while alkaline phosphatase activity on day 90 showed a quadratic trend (PQuadratic = 0.082). (3) Hormone Levels: Plasma insulin and adrenaline levels exhibited quadratic effects on day 60 and 90 of gestation, respectively (PQuadratic < 0.05). (4) Immune Parameters: Plasma immunoglobulin G (IgG) and M (IgM) levels increased linearly with FSHS proportion on day 60 (PLinear < 0.05), but no significant changes were observed on day 90 (p > 0.05). (5) Fecal Microbiota: On day 90, the abundance of actinobacteriota increased quadratically with FSHS levels (PQuadratic < 0.05), while bacteroidota decreased linearly (PLinear < 0.05). During parturition, actinobacteriota abundance continued to increase linearly (PLinear < 0.05). Notably, the FSHS8 group had higher actinobacteriota abundance compared to the control group (p = 0.05). At the genus level, terrisporobacter showed a quadratic increase and then decrease (PQuadratic < 0.05), while ruminococcus showed a quadratic decrease and then increased (PQuadratic < 0.05). Both terrisporobacter in the FSHS2 and FSHS6 groups and ruminococcus in the FSHS8 group were more abundant compared to the control (p < 0.01). Conclusions: Dietary supplementation with FSHS increased fecal microbial diversity, alleviated the incidence of constipation, and ultimately improved sow reproductive performance. The recommended optimal addition of FSHS to the sow diet is 6%.

Ground Flaxseed Supplementation Improved the Energy Utilization and Reduced Oxidative Stress in Buffalo Calves

The present study was conducted at the Department of Veterinary Physiology & Biochemistry and Animal Nutrition, College of Veterinary Science, Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana, Punjab, India during the period of October, 2018 to November, 2019 to evaluate the effect of ground flaxseed supplementation on blood biochemical and metabolic status of buffalo calves. The experiment was performed on four apparently healthy male buffalo calves of 2.0–2.5 years age in this present investigation. They were divided in 2 groups in a switch over design. The animals of Group I were kept as control. The animals of group II were supplemented with Ground Flaxseed @ 15% on dry matter basis replacing oil seed cakes in TMR for 21 days. Blood samples were collected at weekly intervals over a period of 21 days. The results revealed a significant (p<0.05) decrease in plasma glucose and cholesterol values in group II supplemented with ground flaxseed. There was no significant alteration with respect to the plasma total protein, triglycerides, creatinine, urea and total immunoglobulins in any of the groups. The erythrocytic lipid peroxidation was significantly reduced in the flaxseed supplemented group as compared to non-supplemented group. Thus, the present investigation revealed that flaxseed supplementation improved the energy utilization reduced the oxidative stress in animals.

N-Carbamoyl Glutamate Prevents Ammonia Intoxication in Piglets with Reduced Liver Function

Ammonia as the end product of protein catabolism has a depressing effect on neurons. Ammonia neutralization in mammals occurs in the ornithine cycle, the activity of which is regulated mainly at the level of synthesis of N-Carbamoyl phosphate. The Krebs cycle is coupled with the ornithine cycle through a common substrate—arginine succinate. Therefore, the effects of ammonia neutralization and the processes of amino acid and energy metabolism are largely interrelated. This study is aimed at evaluating the efficacy of an N-carbamoyl glutamate additive in terms of optimizing metabolic processes and improving ammonia neutralization in suckling piglets. The experiment was conducted on two groups of piglets (n=15) formed at the age of 24 hours. Piglets in the experimental group were fed with an aqueous solution of the drug at a dose of 10 mg/kg of body weight once daily. The duration of feeding the supplement was 30 days; the average daily gain in body weight was determined at weaning at the age of 30 days. An analysis of the blood biochemical composition was carried out on the 30th day from the onset of the experiment. At the end of feeding the supplement in the experimental group, a decrease in the content of ammonia (p<0.05) and urea in blood plasma, an increase in the concentration of arginine (p<0.05) and triacylglycerols (p<0.05) in comparison with the control group was revealed. The N-carbamoyl glutamate additive under study stimulates the endogenous production of the arginine essential amino acid, neutralizes ammonia formed in metabolic processes, and optimizes the amount of metabolic energy spent on binding ammonia in the urea cycle.

Nephroprotective effects of the soluble guanylyl cyclase stimulator, riociguat in doxorubicin-induced acute kidney injury in rats

This study aimed to investigate the potential protective effects of riociguat, a soluble guanylyl cyclase (sGC) stimulator, on kidney function and structure in rats with acute kidney injury (AKI) induced by the chemotherapeutic drug doxorubicin (DX). Rats were subjected to a single intraperitoneal injection of DX (13.5 mg/kg) on the 5th day, either alone or in combination with low-dose riociguat (3 mg/kg/day), or high-dose riociguat (10 mg/kg/day) for 8 consecutive days. Various markers related to kidney function, oxidative stress, and inflammation were measured in plasma and urine. Kidney tissues were examined histopathologically. DX-induced nephrotoxicity was characterized by increased plasma urea, creatinine, uric acid and neutrophil gelatinase-associated lipocalin (NGAL). DX also decreased creatinine clearance and albumin levels and increased urinary N-acetyl-β-D-glucosaminidase (NAG) activity. Furthermore, DX increased the inflammatory markers interleukin 1 beta (IL-1 β), interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α). DX further induced oxidative stress injury evidenced by decreased glutathione reductase (GR) activity, total antioxidant capacity (TAC), superoxide dismutase (SOD) and catalase levels and increased malondialdehyde (MDA) levels. Concomitant treatment with riociguat ameliorated these DX-induced changes with parallel histopathological improvements but the effects were more favorable with high-dose riociguat. The observed renoprotective effects of riociguat can be partly attributed to the anti-inflammatory and anti-oxidant properties of this drug.

Time course of plasma urea and urinary urea excretion in patients with a prolonged ICU stay

Whereas urinary creatinine excretion (UCE) is an established marker of muscle mass, both in critically ill and non-critically ill patients, analysis of urinary urea excretion (UUE) may allow estimation of proteolysis that is associated with critical illness. We evaluated the time courses of plasma urea and creatinine as well UUE and UCE in critically ill patients with a prolonged ICU stay. Our goal was to evaluate changes in plasma urea and creatinine in conjunction with their urinary excretion, to get a better understanding of urea handling in ICU patients. From 2002 to 2021, plasma urea and creatinine, UUE and UCE were determined in routinely obtained 24 h urine samples between ICU admission and day 30, in adult patients with an ICU-stay ≥ 28d. Urea-to-creatinine ratios in plasma and urine were calculated. Patients with stage 3 acute kidney injury (AKI) were excluded. Analyses were performed separately for females and males and for patients with and without acute renal failure to account for respectively differences in muscle mass and impaired renal function. Of 47,120 patients, who were admitted to the ICU between 2002 and 2021, 638 patients met the inclusion criteria. During the first 10 days mean ± SD plasma urea increased from 9.7 ± 6.0 mmol/L at ICU admission to 12.4 ± 7.9 mmol/L (P < 0.001) on day 11 and decreased afterwards with a rate of 0.1 mmol/l/d. UUE peaked at 590 ± 317 mmol/day on day 13 whereas UCE peaked already on day 4. Males had higher plasma urea, plasma creatinine, UUE and UCE than females. Plasma and urinary urea-to-creatinine ratio (UCR) stabilized after day 7, with a gradual increase in plasma UCR and urinary UCR between day 7 and day 30. Similar courses, although less pronounced, were seen in patients without AKI. The course of urea in critically ill patients is characterized by an initial rise of both plasma urea and urinary urea excretion, presumably due to increased catabolism of endogenous and exogenous protein in the first week of ICU admission. Subsequently, UUE and UCE declined steadily in a rate that was comparable to the known loss of muscle mass during ICU admission of approximately 1%/day.

The Haematotoxicity and Nephrotoxicity Effects of Diazepam Administration in Male Albino Rats

Objectives: This study aimed to assess the haematological and nephrotoxic effects of diazepam at varying doses in male albino rats. Materials and Methods: Rats were administered therapeutic (0.062 mg/kg/day), high (0.33 mg/kg/day), and extremely high (0.661 mg/kg/day) doses of diazepam orally for 14 and 28 days. Blood and kidney samples were collected for haematological and biochemical analysis.Results: Diazepam administration significantly reduced red blood cell count (RBC), packed cell volume (PCV), and platelet count (PLT), while other haematological indices were not notably affected. Plasma creatinine and urea levels increased, and total protein decreased across all doses. The treatment also elevated renal thiobarbituric acid reactive substances (TBARS) levels, while reducing antioxidant enzyme activity superoxide dismutase (SOD), catalase (CAT), and reduced glutathione (GSH). Conclusions: Diazepam poses significant risks of oxidative stress, haematotoxicity, and nephrotoxicity. While effective in managing anxiety, caution is necessary due to its potentially harmful effects on blood and renal function.

Benefit of combination therapy with dapagliflozin and eplerenone on cardiac function and fibrosis in rats with non-diabetic chronic kidney disease

Patients with chronic kidney disease (CKD) are at a high risk of cardiovascular (CV) complications. In these patients, sodium-glucose cotransporter-2 inhibitors (SGLT2i) have been shown to reduce CV events. Mineralocorticoid receptor antagonists (MRAs) exert similar benefits in diabetic CKD, though their effects in non-diabetic CKD remain unclear. This study aimed to evaluated whether the combination of Dapagliflozin (DAPA) and Eplerenone (EPLE) would have positive effects on cardiorenal functions in a non-diabetic CKD model. CKD was induced in rats via 5/6 nephrectomy, followed by treatment with DAPA (5 mg/kg/day PO), EPLE (100 mg/kg/day PO) or the combination for 3 months following CKD induction. Cardiorenal functions were assessed after the treatment period. All treated groups showed reduced kidney fibrosis though plasma creatinine and urea levels remained unchanged. Compared to untreated CKD, EPLE or DAPA/EPLE reduced left ventricle (LV) end-diastolic pressure and LV end-diastolic pressure volume relationship, whereas DAPA alone did not achieve significant reductions. Compared to untreated CKD, EPLE and DAPA/EPLE improved cardiac perfusion but DAPA alone did not. Cardiac fibrosis in CKD was blunted by either DAPA or EPLE alone, with the combination showing an additive effect. In conclusion, co-treatment with DAPA and EPLE enhances diastolic function, cardiac perfusion and reduces myocardial fibrosis in non-diabetic CKD rats.

Rosa roxburghii trattresidue: A novel feed resource for cattle indicated by the non-deleterious performance and blood metabolites.

Rosa roxburghii tratt residue (RRTR) is a regional and uncommon byproduct in Guizhou. Little information is available on whether RRTR can be used as feed for ruminants. In this study, the feasibility of using RRTR as a new feed resource for cattle was investigated by chemical composition analysis, in vitro gas production (Trial 1) and animal feeding experiments (Trial 2). In trial 1, compared to the commonly used fruit residues, RRTR had a proximate nutrient level; the in vitro gas production curve and dynamics fell within the normal range. In trial 2, 16 cattle were allocated to the control and treatment groups, with 8 replicates of 1 cattle each. Cattle in the control group were fed a basal diet without RRTR, while those in the treatment group were fed a diet containing 30% RRTR to replace 30% whole corn silage in basal diet. Feeding RRTR had little effect on the growth performance of the control and treatment cattle (P > 0.05). The feed-to-gain ratio was greater in the treatment group than in the control group throughout the trial period (P < 0.05). The plasma urea levels in the treatment group were lower (P < 0.05) than that in control group, and the levels of other plasma biochemical metabolites were not different between the two groups of cattle (P > 0.05). The in vivo rumen fermentation parameters did not differ between the control and treatment groups (P > 0.05). Our findings indicate that RRTR has a nutritional profile (crude protein, neutral detergent fiber, acid detergent fiber, and crude fiber) similar to that of commonly used fruit residues (such as apple, pineapple, and citrus residue et al.); improves plasma protein utilization efficiency; and has no negative impact on growth performance, albeit with limited effects on feed conversion; blood metabolites, and rumen fermentation parameters in cattle. Accordingly, we conclude, based on the above-mentioned result, that RRTR can serve as a novel feed alternative resource when considering the affordability and as a practical choice for low-cost diets for cattle.

Nitrogen fertiliser application rate to temperate mid-season grass: Digestion, nitrogen balance and rumen microbiota in beef cattle, and rumen fermentation and methane production in vitro

Nitrogen (N) excretion by cattle, particularly urinary N, can have detrimental environmental impacts on air and water quality, and contributes to greenhouse gas emissions. The effects of increasing the application rate of inorganic N fertiliser from 15 (N15) to 80 (N80) kg/ha per cut to Lolium perenne dominant swards in summer, on intake, rumen fermentation, rumen microbial populations, apparent total-tract digestibility and N-balance in beef cattle, and in vitro fermentation and methane output, were studied. Sixteen suckler-bred Charolais steers, used in a randomised block design experiment, were offered fresh grass mechanically harvested 21-d after N fertiliser application. Similar grass was incubated in an eight-vessel in vitro RUSITEC system. Grass crude protein concentration was 50 g/kg dry matter (DM) higher for N80 compared to N15. There was no difference in grass DM intake between treatments. Rumen fermentation variables did not differ between treatments, except for the molar proportion of propionate, which was greater for N80 than N15. Gross microbial community structure in the rumen was not significantly altered by inorganic N fertiliser application rate. The relative abundance of individual genera Lachnospiraceae_NK3A320_group and Ruminococcaceae_NK4A214_group, and Acetitomaculum were significantly lower at the higher N application rate. Mean plasma urea concentration was greater for N80 compared to N15. In vivo digestibility of DM, organic matter, neutral detergent fibre and acid detergent fibre was unaffected by fertiliser N application rate. Nitrogen intake was 75 g/d greater, and urinary and faecal N excretion were 20 and 5 g/d greater, respectively, for N80 than N15. The quantity of N retained and N use efficiency was greater for N80 compared to N15. In vitro NH3 concentration was greater for N80 than N15, whereas other rumen fermentation variables, and in vitro methane and total gas output, did not differ between treatments. Reducing the inorganic N fertiliser rate applied to mid-season temperate grass reduced N excretion from beef cattle, which is environmentally beneficial, with no effect on in vitro methane production.

Metabolomic characterization of human glioblastomas and patient plasma: a pilot study

Background Glioblastoma (GBM) is a clinically challenging primary brain tumor with poor survival outcome despite surgical resection and intensive chemoradiation. The metabolic heterogeneity of GBM can become biomarkers for treatment response, resistance, and outcome prediction. The aim of the study is to investigate metabolic distinctions between primary and recurrent GBM tissue and patient plasma to establish feasibility for metabolic profiling. Methods A single-center cohort study analyzed tissue and blood samples from 15 patients with GBM using untargeted metabolomic/lipidomic assays. Metabolomic, lipidomic, and biogenic amine analyses were conducted on GBM tissue and patient plasma at diagnosis and recurrence using untargeted mass spectrometry. The study utilized a small but longitudinally collected cohort to evaluate alteration in metabolites, lipids, and biogenic amines between specimens at diagnosis and recurrence. Results Exploratory analysis revealed significant alteration in metabolites, lipids, and biogenic amines between diagnostic and recurrent states in both tumor and plasma specimens. Notable metabolites differed at recurrence, including N-alpha-methylhistamine, glycerol-3-phosphate, phosphocholine, and succinic acid in tissue, and indole-3-acetate, and urea in plasma. Principal component analysis revealed distinct metabolomic profiles between tumor tissue and patient plasma. Distinct metabolic profiles were observed in GBM tissue and patient plasma at recurrence, demonstrating the feasibility of using metabolomic methodologies for longitudinal studies. One patient exhibited a unique tumor resistance signature at diagnosis, possibly indicating a high-risk metabolomic phenotype. Conclusions In this small cohort, the findings suggest the potential of metabolomic signatures of GBM tissue and patient plasma for risk stratification, outcome prediction, and the development of novel adjuvant metabolic-targeting therapies. The findings suggest metabolic discrepancies at diagnosis and recurrence in tissue and plasma, highlighting potential implications for evaluation of clinical response. The identification of significant changes in metabolite abundance emphasizes the need for larger studies using targeted metabolomics to validate and further explore these profiles.

Effects of Supplementing Different Quantities of Moringa stenopetala Leaves on Plasma Metabolite and Acylcarnitine Profile, Body Condition Score and Milk Yield Performance in Zebu (Bos indicus) Cattle.

The formulation of multi-nutrient blocks based on low-cost and locally available browse feed resources can be a valid feeding strategy in Sub-Saharan Africa, where inadequate feed supply, both in quality and quantity, is a major constraint. We evaluated the four different inclusion percentages (M-0%, M-25%, M-35% and M-45%) of Moringa stenopetala leaf powder to multi-nutrient blocks on their change on blood metabolite of dairy cows under practical, ranging conditions. Multi-nutrient blocks with four inclusion rates of M. stenopetala leaves were applied as complementary feed for free ranging dairy cows. The study was performed on 24 free ranging dairy cows reared around Arba Minch town in the Southern Ethiopian Rift Valley. Blood samples were collected from the jugular vein of dairy cows both before and after supplementation. Plasma glucose, beta hydroxy butyrate (BHB), urea, creatinine, triglycerides and nonesterified fatty acids (NEFA) concentration was quantified spectrophotometrically. Dried serum spots were subject to quantitative electrospray tandem mass spectrometry to estimate changes in nutrient metabolism based on selected carnitines. Based on these measurements, the milk yield and body condition score were increased during the period of multi-nutrient block supplementation. During the supplementation period, the cows got higher plasma glucose, triglyceride and urea concentrations and lower concentrations of BHB, NEFA and creatinine. From the metabolite profiles, a more efficient nutrient use could be concluded. Although no clear dose-response relationship was observed, the highest inclusion of the M. stenopetala leaves in the multi-nutrient blocks gave the best performance. This outcome supports the idea of implementing M. stenopetala based multi-nutrient blocks on tropical smallholder farms that are not easily accessible to conventional extension services.

PSII-27 Dietary fiber fractions supplementation modulates pro-inflammatory cytokines, hindgut ammonia-nitrogen concentration, and diarrhea severity of nursery pigs

Abstract Dietary fiber may functionally modulate the intestinal health of pigs depending on the content of dietary fiber fraction (DFF). The objective of this study was to investigate the effects of DFF based on soluble dietary fiber (SDF) and insoluble dietary fiber (IDF) ratio on growth performance, blood parameters, hindgut ammonia-nitrogen concentrations, and diarrhea severity (fecal consistency score, FCS) of nursery pigs. Mixed-sex pigs (n = 200) with an average body weight (BW) of 7.56 ± 0.86 kg were randomly assigned to 1 of 5 dietary treatments in a randomized complete block design, with 5 pigs per pen and 8 pens per treatment. Pigs were fed a basal diet (BD, containing 8.80% IDF and 0.70% SDF), or the BD diet supplemented with dietary fiber to provide an additional 2% DFF to provide SDF and IDF, from inulin and lignocellulose, respectively, in ratios of 1:1 (DFF1), 1:3 (DFF2), 1:5 (DFF3), and 1:7 (DFF4) for 28 d. Overall, there were no dietary effects on ADFI, ADG, and F:G (P &amp;gt; 0.05). Compared with the BD diet, there was no overall effect of DFF on blood parameters, except for reduced plasma interleukin (IL) -6 and IL-1β concentrations (P &amp;lt; 0.05). Plasma IL-6 was reduced in DFF1 by 20.1%, while plasma IL-1β was reduced in DFF2, DFF3, and DFF4 by average 20% (P &amp;lt; 0.05). Decreasing SDF:IDF ratio increased plasma urea nitrogen (P &amp;lt; 0.05) and tended to decrease plasma myeloperoxidase (P &amp;lt; 0.10) in a quadratic manner. Amongst all treatments, pigs fed DFF1 or DFF2 diet had the least plasma content of superoxide dismutase while pigs fed DFF3 had the greatest (P &amp;lt; 0.05). Pigs fed DFF, regardless of SDF:IDF ratio, had reduced cecal and colonic ammonia-nitrogen compared with BD (P &amp;lt; 0.01). Overall, FCS was reduced by DFF compared with BD (P &amp;lt; 0.001). Decreasing SDF:IDF ratio reduced FCS in a quadratic manner (P &amp;lt; 0.05). The results indicate that 2% DFF supplementation with inulin and lignocellulose, regardless of the SDF:IDF, modulated pro-inflammatory cytokines, hindgut ammonia-nitrogen concentration, and diarrhea severity in nursery pigs.

402 The effect of supplemental protein degradability and frequency of supplementation on nitrogen metabolism of beef cattle consuming low-quality forage

Abstract Rumen degradable protein (RDP) is required for cattle consuming low-quality forage to ensure adequate fiber digestion. However, in situations where cattle are not supplemented daily, supplementing RDP could overwhelm the nitrogen recycling mechanisms, leading to increased nitrogen excretion. The objective of this experiment was to determine the effect of rumen degradability and frequency of supplemental protein in beef cattle consuming low-quality forage. Treatments were arranged in a 2 × 2 factorial with protein degradability (68.5% or 32.8% RDP) and supplementation frequency (daily or biweekly) as the two factors. Ruminally cannulated Angus steers [n = 8; body weight (BW) = 328 ± 12.2 kg] were used in a Latin rectangle. The low RDP treatment was composed of 50% soybean hulls and 50% corn gluten meal (40.3% CP; 32.8% RDP), and the high RDP treatment consisted of 45.4% soybean hulls, 41.4% soybean meal, 4.1% urea, and 9.1% molasses (40% CP; 68.5% RDP). The biweekly steers were supplemented on d 0, 4, 7, 11, 14, 18, and 21 of each period. Steers were given ad libitum access to low-quality (7.4% CP) native grass hay. Daily blood samples were collected from d 14 to 17 at 0630 h and d 21 at -2, 3, and 7 h relative to supplementation. Rumen fluid samples were collected every 4 h on d 18 to 21. Daily NEFA concentrations decreased (P &amp;lt; 0.001) post-supplementation in the biweekly supplemented steers and then returned to baseline values, while the daily supplemented steers had no change. Hourly NEFA concentrations in steers supplemented with high RDP biweekly increased from 2 h pre-supplementation to 3 h post-supplementation (P &amp;lt; 0.001), then decreased at 7 h post-supplementation back to pre-supplementation concentrations. Plasma urea nitrogen (PUN) increased in biweekly high RDP supplemented steers 1 d after supplementation (P &amp;lt; 0.001) and decreased from d 15 to d 17. PUN concentrations increased from 2 h pre-supplementation through 7 h post-supplementation in both high RDP treatments, while low RDP treatments did not change (P &amp;lt; 0.001). Rumen fluid lactate and ammonia concentrations rapidly increased in the biweekly high RDP-supplemented steers in response to each supplementation (P &amp;lt; 0.001). There were spikes in ammonia concentrations for the daily high RDP treatment post-supplementation; however, they were smaller in magnitude compared with the biweekly high RDP. The low RDP treatments remained steady across all hours of ammonia sampling, where daily and biweekly supplemented steers decreased slightly in the time points following supplementation and then gradually increased. Rumen pH displayed drastic changes in the biweekly high RDP-supplemented group with values ranging from 6.99 to 5.97 (P &amp;lt; 0.001), but the low RDP treatments remained consistent. Supplementing biweekly with high RDP resulted in fluctuations in metabolites not observed in the other treatments, which could reduce forage utilization and increase nitrogen excretion.

Relationship between Plasma and Saliva Urea Nitrogen Concentrations in New Zealand Red Deer Calves (Cervus elaphus).

Red deer (Cervus elaphus), like other ruminants, excrete approximately 70% of the nitrogen they ingest. Developing ways in which to reduce the rate of loss, such as manipulating the diet or selecting for efficiency of growth, requires close monitoring of the plasma urea N (PUN) concentration which, in turn, requires a simple, safe, and reliable method for collecting samples. Saliva is easier to collect than blood, but the relationship between the salivary urea N (SUN) and the PUN is not known for red deer. This was therefore evaluated in two strains of mixed-sex red deer calves (Cervus elaphus): a phenotype with a high seasonality of growth (H, n = 10) and a phenotype with a low seasonality of growth (L, n = 13). Both phenotypes were divided into two groups, which were each offered one of two forage-based diets ad libitum: a medium-quality diverse treatment and a low-quality perennial ryegrass-white clover treatment. Blood and saliva samples for the determination of the PUN and SUN were collected at dawn every four weeks for five months (April to September 2022). There was a strong linear relationship between the PUN and SUN in the pooled sample (R2 = 0.65, p < 0.001). The estimations of the PUN were significantly improved by adding diet and the date of sampling into the model (p < 0.001), but not phenotype (p > 0.75). SUN represents a reliable index of the PUN, and collecting saliva therefore represents a simple and inexpensive alternative to collecting blood samples in studies of nitrogen metabolism in red deer.

P224 EFFECT OF SODIUM NITRITE ON RENAL DAMAGE FROM 2-KIDNEY, 1-CLIP (2K-1C) HYPERTENSION IN RATS

Renovascular hypertension is characterized by oxidative stress and decreased availability of nitric oxide (NO). Nitrite is a physiologically recycled metabolite that generates NO. Treatment with sodium nitrite has antihypertensive effects due to its antioxidant capacity. However, the renal effects of this treatment are not known in 2K1C hypertension. This study aims to evaluate the effect of treatment with sodium nitrite on kidney damage caused by 2K1C hypertension. Hypertension was induced by cleavage of the left renal artery in Wistar rats. Two weeks after surgery, the animals were treated with two doses (1 mg/kg/day or 15 mg/kg/day) of sodium nitrite or vehicle for 4 weeks, by gavage. Blood pressure (BP) was checked weekly by tail plethysmography. To assess renal function, plasma urea and creatinine were determined. Kidney oxidative stress was evaluated through the activity of catalase (CAT), superoxide dismutase (SOD), levels of reduced glutathione (GSH), lipid peroxidation, and superoxide (O2-) levels. Treatment with 15 mg/kg/day of sodium nitrite reversed the increase in BP in 2K1C rats (p&lt;0.05, 2K1C:170.5±6.542; 2K1C+Nitrite15:162.4±6.712 mmHg), and improved renal function previously impaired by hypertension (urea, p&lt;0.05; 2K1C:76.37±24.53; 2K1C+Nitrite15:47.82±13.86; creatinine, p&lt;0.05; 2K1C:0.540±0.105; 2K1C+Nitrite15:0.3550±0.117). SOD activity decreased in the kidneys of hypertensive animals (p&lt;0.05, Control:0.7176±0.06426; 2K1C:0.636±0.0888; 2K1C+Nitrite1:0.703±0.0866; 2K1C+Nitrite15:0.648±0.173). As for CAT and GSH, there was a decrease in activity in hypertensive animals, with improvement in the group treated with nitrite 15 mg/kg/day (CAT p&lt;0.05, Control:0.651±0.255; 2K1C:0.2772±0.1837; 2K1C+Nitrite15: 0.6654±0.1440 and GSH: p&lt;0.05, Control:44.80±10.59; 2K1C: 29,62±7,253 2K1C+Nitrite15:44.25±10.07). Lipid peroxidation increased by hypertension was reduced with treatment at the highest dosage (p&lt;0.05, Control:0.314±0.158; 2K1C:0.497±0.113; 2K1C+Nitrite15:0.278±0.084). O2- levels were decreased in all groups treated with nitrite (p&lt;0.05, 2K1C:3.844±1.598; 2K1C+Nitrite1:0.9643±0.2063; 2K1C+Nitrite15:0.4431±0.1838). Our results suggest that sodium nitrite treatment improves 2K1C renal damage through its antioxidant activity. Acknowledgments: FAPEMIG# APQ-00946-23, CNPq# 302076/2022-0

The Effect of Different Forms of Solid Feed on Biochemical Parameters in Blood Plasma of Calves

Abstract The study examined how different solid feeds affected the biochemical parameters in calf plasma. The experiment involved a control group and three test groups of calves, each fed with a different starter mixture. The results showed significant differences in some biochemical parameters between the feeding groups. Calves in groups P1 and P3 had a statistically higher glucose concentration in blood plasma compared to group C. Calves from group P3 had a higher concentration of urea in blood plasma than calves from group C. Calves in groups P1 and P3 also had higher concentrations of total protein and globulin in blood plasma compared to group C. The concentration of inorganic phosphate in the blood plasma of calves from group P3 was significantly higher than that of group C. Female calves in the experimental groups showed a lower concentration of NEFA at three months of age compared to the control group. It was concluded that feeding calves with a starter mixture containing whey and easily digestible protein had a positive effect on the nutritional status and energy balance of the calves.

Effect of Grape Seed Proanthocyanidins Supplement on the Incidence of Recurrent Urinary Tract Infections in a Sample of Iraqi Diabetic Patients

Background: Proanthocyanidin is often used to prevent urinary tract infections (UTIs) in susceptible E. coli strains. Objective: To explore how grape seed proanthocyanidin extract (GSPE) affects type 2 diabetic patients (T2DM) with recurrent urinary tract infections (rUTIs). Method: The efficacy of GSPE in the treatment of T2DM with rUTIs was assessed in this randomized, single-blind controlled study. Sixty adults with diagnosed T2DPs and urinary tract infections were randomly assigned to treatment for 12 weeks with metformin (0.5 g t.i.d.) in Group A (Control Group) and a combination of GSPE (300 mg q.d.) and metformin (0.5 g t.i.d.), Group B, with the end of follow-up being 24 weeks, according to the study. Results: The medicinal plant GSPE reduces the recurrence of urinary tract infections in patients with T2DM after 12 weeks of treatment, compared with pre-treatment values and the control group. After 12 weeks of treatment for T2DM, fasting plasma glucose levels, creatinine, urea, and uric acid in both groups decreased non-significantly compared to control. There were fewer recurrent UTIs in the intervention group (77.8%), the control group (48.1%), and the GSPE (7.1%), compared to the control group (12.7%), the GSPE (7.1%), and the intervention group (33.7%) over the course of 24 weeks. Conclusions: Utilizing GSPE to treat, prevent, and minimize recurrent urinary tract infections in T2DM will help them better grasp the benefits and hazards associated with the daily administration of an appropriate GSPE dose.

O53 RENOMETABOLIC DISORDER IN EXPERIMENTAL RAT MODEL OF PCOS IS REVERSED VIA INHIBITION OF PYRUVATE DEHYDROGENASE KINASE 4

Background and Objective: Chronic Kidney disorders is a global public health problem, including in women with polycystic ovarian syndrome (PCOS), and is characterized by renal fibrosis, nephrotoxicity and glomerulonephritis, which increases the possibility of renal failure and organ transplant. Pyruvate dehydrogenase kinase 4 (PDK4) has been implicated in mitochondria dysfunction, contributing to metabolic dysregulation in different organs, including kidney. Studies have shown the metabolic regulatory impact of probiotics in human and experimental models. Hence, the present study investigated the therapeutic potential of probiotics on renometabolic disorders associated with experimental PCOS model. The study in addition elucidates the probable involvement of PDK4 in PCOS-associated renometabolic disorders. Methods: Eight-week-old nulliparous female Wistar rats were randomly allotted into four groups (n=6). Letrozole (1 mg/kg) was used to induce PCOS for 3 weeks. Thereafter, probiotics (2 x 107 CFU) was administered for 6 weeks, uninterruptedly. Biochemical parameters, histological analysis, immunohistochemistry and gene expression were carried out with appropriate methods. Results Experimental PCOS rats were characterized with elevated circulating testosterone and the presence of multiple ovarian cysts. In addition, rat with PCOS also manifested insulin resistance, increased plasma urea and creatinine levels, increased renal Gamma glutamyltransferase (GGT), MDA, NF-kappa B, TNF-alpha, TGF-beta 1, caspase-6, HDAC2, while a decrease in G6PD, GSH, renal NO and eNOS, when compared with animals in the control rats. These were associated with elevated level of PDK4 in the renal tissue. However, administration of probiotics ameliorates these renal/metabolic abnormalities. Conclusion: Altogether, the results from the present study revealed that probiotics ameliorates renal dysfunction in PCOS via downregulation of PDK4.

Metabolomic characterization of human glioblastomas and patient plasma: a pilot study

Background Glioblastoma (GBM) is a clinically challenging primary brain tumor with poor survival outcome despite surgical resection and intensive chemoradiation. The metabolic heterogeneity of GBM can become biomarkers for treatment response, resistance, and outcome prediction. The aim of the study is to investigate metabolic distinctions between primary and recurrent GBM tissue and patient plasma to establish feasibility for metabolic profiling. Methods A single-center cohort study analyzed tissue and blood samples from 15 patients with GBM using untargeted metabolomic/lipidomic assays. Metabolomic, lipidomic, and biogenic amine analyses were conducted on GBM tissue and patient plasma at diagnosis and recurrence using untargeted mass spectrometry. The study utilized a small but longitudinally collected cohort to evaluate alteration in metabolites, lipids, and biogenic amines between specimens at diagnosis and recurrence. Results Exploratory analysis revealed significant alteration in metabolites, lipids, and biogenic amines between diagnostic and recurrent states in both tumor and plasma specimens. Notable metabolites differed at recurrence, including N-alpha-methylhistamine, glycerol-3-phosphate, phosphocholine, and succinic acid in tissue, and indole-3-acetate, and urea in plasma. Principal component analysis revealed distinct metabolomic profiles between tumor tissue and patient plasma. Distinct metabolic profiles were observed in GBM tissue and patient plasma at recurrence, demonstrating the feasibility of using metabolomic methodologies for longitudinal studies. One patient exhibited a unique tumor resistance signature at diagnosis, possibly indicating a high-risk metabolomic phenotype. Conclusions In this small cohort, the findings suggest the potential of metabolomic signatures of GBM tissue and patient plasma for risk stratification, outcome prediction, and the development of novel adjuvant metabolic-targeting therapies. The findings suggest metabolic discrepancies at diagnosis and recurrence in tissue and plasma, highlighting potential implications for evaluation of clinical response. The identification of significant changes in metabolite abundance emphasizes the need for larger studies using targeted metabolomics to validate and further explore these profiles.

Pharmacokinetic profiling of ZCL-278, a cdc42 inhibitor, and its effectiveness against chronic kidney disease

ZCL-278 is a selective small molecule specifically inhibiting the Cdc42-intersectin interaction, yet its in-vivo pharmacokinetic and pharmacodynamic properties against renal diseases had not been determined. Thus, our study explored the absorption, distribution and excretion of ZCL-278 as well as its pharmacological efficacy against chronic kidney disease (CKD). With the optimized detection method, absolute oral bioavailability of ZCL-278 was determined as 10.99 % in male and 17.34 % in female rats. ZCL-278 was rapidly and abundantly distributed in various tissues, especially the kidney and heart, while few excreted through urine and feces. In the adenine-induced CKD mice, the increased plasma creatinine and urea, the decreased body weight as well as the renal pathological alterations, including vacuolization of renal tubular epithelial cells, granular degeneration, cell flattening, luminal dilation, and cylindruria, were significantly ameliorated after ZCL-278 administration. Moreover, ZCL-278 could also reverse the increased intensities of renal inflammation and fibrosis in the CKD mice. These results clarified the pharmacokinetics of ZCL-278 in rats and preliminarily indicated that ZCL-278 has favorable pharmacodynamic properties for CKD primed for lead development and optimization, warranting further drug development.